Multi-Scale Spatial Analysis of the Tumor Microenvironment Reveals Features of Cabozantinib and Nivolumab Efficacy in Hepatocellular Carcinoma.
Front Immunol. 2022 May 13;13:892250. doi: 10.3389/fimmu.2022.892250. eCollection 2022.
Front Immunol. 2022.
PMID: 35634309
Free PMC article.